Abstract
Understanding midazolam involves understanding its chemistry, pharmacokinetics, and pharmacodynamics. These are the topics where holding a clinician’s attention will be challenging. But they are the foundations that will lead to optimal clinical utilization of a drug, and the chapter emphasizes this fact. The water solubility of midazolam, its importance, the reasons for the quick onset of action along with the short duration of clinical action, the safety profile of midazolam related to its pharmacodynamics, understanding properties like amnesia and paradoxical reactions, and utilizing this understanding into clinical advantages are topics dealt within this chapter.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Riss J, Cloyd J, Gates J, Collins S. Benzodiazepines in epilepsy: pharmacology and pharmacokinetics. Acta Neurol Scand. 2008;118(2):69–86. https://doi.org/10.1111/j.1600-0404.2008.01004.x.
Batlle E, Lizano E, Vinas M, Pujol MD. Benzodiazepines and new derivatives: description, analysis, and organic synthesis. In: Intechopen. November 5, 2018. https://www.intechopen.com/books/medicinal-chemistry/1-4-benzodiazepines-and-new-derivatives-description-analysis-and-organic-synthesis. Accessed 21 July 2020. Doi: https://doi.org/10.5772/interchopen.79879.
Gerecke M. Chemical structure and properties of midazolam compared with other benzodiazepines. Br J Clin Pharmacol. 1983;16 Suppl 1:11S–6S. https://doi.org/10.1111/j.1365-2125.1983.tb02266.x.
Pieri L. Preclinical pharmacology of midazolam. Br J Clin Pharmacol. 1983;16 Suppl 1:17S–27S. https://doi.org/10.1111/j.1365-2125.1983.tb02267.x.
Imidazole. In: Wikipedia the free encyclopedia. https://en.wikipedia.org/wiki/Imidazole. Accessed 21 July 2020.
Pharmacology. In: Malamed SJ, editor. Sedation: a guide to patient management, 6th ed. St. Louis: Mosby Elsevier; 2010, pp. 319–58.
Kanto JH. Midazolam: the first water-soluble benzodiazepine. Pharmacology, pharmacokinetics and efficacy in insomnia and anesthesia. Pharmacotherapy. 1985;5(3):138–55. https://doi.org/10.1002/j.1875-9114.1985.tb03411.x.
Pieri L, Schaffner R, Scherschlicht R, et al. Pharmacology of midazolam. Arzneimittelforschung. 1981;31(12a):2180–201.
Walbergh EJ, Wills RJ, Eckhert J. Plasma concentrations of midazolam in children following intranasal administration. Anesthesiology. 1991;74(2):233–5. https://doi.org/10.1097/00000542-199102000-00007.
Pharmacokinetics, pharmacodynamics, and drug interactions. In: Basic medical key https://basicmedicalkey.com/pharmacokinetics-pharmacodynamics-and-drug-interactions/. Accessed 21 July 2020.
Reves JG, Fragen RJ, Vinik HR, Greenblatt DJ. Midazolam: pharmacology and uses. Anesthesiology. 1985;62(3):310–24.
Midazolam. In: DrugBank. https://www.drugbank.ca/drugs/DB00683. Accessed 21 July 2020.
Kanto J, Allonen H. Pharmacokinetics and the sedative effect of midazolam. Int J Clin Pharmacol Ther Toxicol. 1983;21(9):460–3.
Pacifici GM. Clinical pharmacology of midazolam in neonates and children: effect of disease-a review. Int J Pediatr. 2014;2014:309342. https://doi.org/10.1155/2014/309342. Epub 2014 Feb 18.
Alzahrani AM, Wyne AH. Use of oral midazolam sedation in pediatric dentistry: a review. Pak Oral Dent J. 2012;32(3):444–55.
Backman JT, Olkkola KT, Ojala M, Laaksovirta H, Neuvonen PJ. Concentrations and effects of oral midazolam are greatly reduced in patients treated with carbamazepine or phenytoin. Epilepsia. 1996;37(3):253–7. https://doi.org/10.1111/j.1528-1157.1996.tb00021.x.
Hayashi T, Higuchi H, Tomoyasu Y, Ishii-Maruhama M, Maeda S, Miyawaki T. Effect of carbamazepine or phenytoin therapy on blood level of intravenously administered midazolam: a prospective cohort study. J Anesth. 2016;30(1):166–9. https://doi.org/10.1007/s00540-015-2063-3.
Payne K, Mattheyse FJ, Liebenberg D, Dawes T. The pharmacokinetics of midazolam in paediatric patients. Eur J Clin Pharmacol. 1989;37(3):267–72. https://doi.org/10.1007/BF00679782.
Griffin CE 3rd, Kaye AM, Bueno FR, Kaye AD. Benzodiazepine pharmacology and central nervous system-mediated effects. Ochsner J. 2013;13(2):214–23.
Kaufmann WA, Humpel C, Alheid GF, Marksteiner J. Compartmentation of alpha 1 and alpha 2 GABA(A) receptor subunits within rat extended amygdala: implications for benzodiazepine action. Brain Res. 2003;964(1):91–9. https://doi.org/10.1016/s0006-8993(02)04082-9.
Crestani F, Löw K, Keist R, Mandelli M, Möhler H, Rudolph U. Molecular targets for the myorelaxant action of diazepam. Mol Pharmacol. 2001;59(3):442–5. https://doi.org/10.1124/mol.59.3.442.
Study RE, Barker JL. Cellular mechanisms of benzodiazepine action. JAMA. 1982;247(15):2147–51.
Kupietzky A, Houpt MI. Midazolam: a review of its use for conscious sedation of children. Pediatr Dent. 1993;15(4):237–41.
Payne KA, Coetzee AR, Mattheyse FJ. Midazolam and amnesia in pediatric premedication. Acta Anaesthesiol Belg. 1991;42:101–5.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2024 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Rao, A., Tiwari, S. (2024). Understanding Midazolam: The Key to Its Safe Clinical Use. In: Midazolam in Pediatric Dentistry. Springer, Cham. https://doi.org/10.1007/978-3-031-45147-8_2
Download citation
DOI: https://doi.org/10.1007/978-3-031-45147-8_2
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-45146-1
Online ISBN: 978-3-031-45147-8
eBook Packages: MedicineMedicine (R0)